Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis

Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George, Sander W. van der Laan, Rainer Malik, Christian Herder, Wolfgang Koenig, Thor Ueland, Ola Kleveland, Pal Aukrust, Lars Gullestad, Jürgen Bernhagen, Gerard Pasterkamp, Annette Peters, Aroon D. Hingorani, Jonathan Rosand, Martin Dichgans, Christopher D. Anderson, Marios K. Georgakis
doi: https://doi.org/10.1101/2023.03.24.23287543

Article Information

doi 
https://doi.org/10.1101/2023.03.24.23287543
History 
  • March 28, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Savvina Prapiadou1,2,3,
  2. Luka Živković4,
  3. Barbara Thorand, PhD5,
  4. Marc J. George, MB, ChB, PhD6,
  5. Sander W. van der Laan, PhD7,
  6. Rainer Malik, PhD4,
  7. Christian Herder, PhD8,9,10,
  8. Wolfgang Koenig, MD11,12,13,
  9. Thor Ueland, PhD14,15,16,
  10. Ola Kleveland, MD, PhD17,18,
  11. Pal Aukrust, MD, PhD15,16,19,
  12. Lars Gullestad, MD, PhD20,
  13. Jürgen Bernhagen, PhD4,11,21,
  14. Gerard Pasterkamp, MD7,
  15. Annette Peters, PhD5,22,23,
  16. Aroon D. Hingorani, MB, BS, PhD6,24,
  17. Jonathan Rosand, MD2,3,25,
  18. Martin Dichgans, MD4,11,19,26,
  19. Christopher D. Anderson, MD, MMSc2,3,27 and
  20. Marios K. Georgakis, MD, PhD3,4,*
  1. 1University of Patras School of Medicine, Patras, Greece
  2. 2Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
  3. 3Broad Institute of MIT and Harvard, Cambridge, MA, USA
  4. 4Institute for Stroke and Dementia Research, Ludwig-Maximilians-University of Munich, Munich, Germany
  5. 5Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
  6. 6Department of Clinical Pharmacology, Division of Medicine, University College London, London, United Kingdom
  7. 7Central Diagnostics Laboratory, Division Laboratories, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
  8. 8German Center for Diabetes Research, Partner Düsseldorf, Düsseldorf, Germany
  9. 9Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany
  10. 10Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, Düsseldorf, Germany
  11. 11German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
  12. 12Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
  13. 13German Heart Center Munich, Technical University of Munich, Munich, Germany
  14. 14Thrombosis Research Center (TREC), Division of internal medicine, University hospital of North Norway, Tromsø, Norway
  15. 15Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
  16. 16Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  17. 17Clinic of Cardiology, St Olavs Hospital, Trondheim, Norway
  18. 18Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway
  19. 19Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway
  20. 20Department of Cardiology Oslo University Hospital Rikshospitalet, Oslo, Norway
  21. 21Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
  22. 22Chair of Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany
  23. 23Munich Heart Alliance, German Center for Cardiovascular Health (DZHK e.V., partner-site Munich), Munich, Germany
  24. 24Centre for Translational Genomics, Institute of Cardiovascular Science, University College London, London, United Kingdom
  25. 25Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
  26. 26German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
  27. 27Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
  1. ↵*Address for Correspondence:
    Marios K. Georgakis, MD, PhD, Research Group Leader “Epidemiology and Bioinformatics” & Clinician-Scientist (Neurology), Institute for Stroke and Dementia Research, Ludwig-Maximilians-University Hospital, Feodor-Lynen-Str. 17, 81377 Munich, Germany, Tel: +49-89-4400-46127, Fax: +49-89-4400-46040, E-mail: marios.georgakis{at}med.uni-muenchen.de; mgeorgak{at}broadinstitute.org
Back to top
Posted March 28, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis
Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George, Sander W. van der Laan, Rainer Malik, Christian Herder, Wolfgang Koenig, Thor Ueland, Ola Kleveland, Pal Aukrust, Lars Gullestad, Jürgen Bernhagen, Gerard Pasterkamp, Annette Peters, Aroon D. Hingorani, Jonathan Rosand, Martin Dichgans, Christopher D. Anderson, Marios K. Georgakis
medRxiv 2023.03.24.23287543; doi: https://doi.org/10.1101/2023.03.24.23287543
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area